The ultimate goal of this Component is to identify mouse genes which contribute to the Down syndrome-like phenotype in mouse mutants trisomeric for regions syntenic with human chromosome 21. The success of the Ts65Dn model, following on that of the trisomy 16 model, clearly demonstrates the utility of mouse models of Down syndrome. At the same time, the genotype/phenotype study of human partial trisomies have proven to be a robust mapping method, although the rarity of human partial trisomies has made progress slow. We propose to apply the partial trisomy mapping method to the mouse mode, but rather than rely on rare, and unsystematic, natural trisomies, we will use the Cre/lox site specific recombination system to engineer a specific, systematic set of segmental deletions and duplications, either """"""""adding"""""""" or """"""""subtracting"""""""" large regions from the Ts65Dn trisomy model. Specifically, we will introduce lox sites by homologous recombination in murine embryonic stem cells at various loci in three regions: on chromosome 16 within 1 Mb of the AML1 locus and within a 2 Mb regions between the Wv and Erg loci, and on chromosome 17 in a 1 Mb regions region around Cbs. We will then catalyze the recombination between these lox sites, either in Es cell in culture or in fertilized oocytes, by transient expression of the Cre recombinase. Through analysis of mutant mice carrying these duplication or deletions in the Ts65Dn background, we will correlate trisomy of specific regions with particular aspects of the DS phenotype; and then candidate genes from these regions, identified in the Gene Identification Core, will be tested directly.

Project Start
2001-01-01
Project End
2001-12-31
Budget Start
Budget End
Support Year
18
Fiscal Year
2001
Total Cost
Indirect Cost
Name
Eleanor Roosevelt Institute for Cancer Research
Department
Type
DUNS #
City
Denver
State
CO
Country
United States
Zip Code
80206
Régnier, Vinciane; Billard, Jean-Marie; Gupta, Sapna et al. (2012) Brain phenotype of transgenic mice overexpressing cystathionine ?-synthase. PLoS One 7:e29056
Moat, Stuart; Carling, Rachel; Nix, Authur et al. (2010) Multicentre age-related reference intervals for cerebrospinal fluid serine concentrations: implications for the diagnosis and follow-up of serine biosynthesis disorders. Mol Genet Metab 101:149-52
Nielsen, Darci M; Evans, Jeffrey J; Derber, William J et al. (2009) Mouse model of fragile X syndrome: behavioral and hormonal response to stressors. Behav Neurosci 123:677-86
Knox, Aaron J; Graham, Christine; Bleskan, John et al. (2009) Mutations in the Chinese hamster ovary cell GART gene of de novo purine synthesis. Gene 429:23-30
Hoger, Joachim; Patterson, David; Hoger, Harald et al. (2009) Mice transgenic for reduced folate carrier: an animal model of Down syndrome? Amino Acids 36:349-57
Patterson, David; Graham, Christine; Cherian, Christina et al. (2008) A humanized mouse model for the reduced folate carrier. Mol Genet Metab 93:95-103
Pennington, Bruce F (2006) From single to multiple deficit models of developmental disorders. Cognition 101:385-413
Yao, Guimei; Chen, Xiao-Ning; Flores-Sarnat, Laura et al. (2006) Deletion of chromosome 21 disturbs human brain morphogenesis. Genet Med 8:1-7
Wenger, Galen R; Schmidt, Cecilia; Davisson, Muriel T (2004) Operant conditioning in the Ts65Dn mouse: learning. Behav Genet 34:105-19
Gardiner, Katheleen; Davisson, Muriel T; Crnic, Linda S (2004) Building protein interaction maps for Down's syndrome. Brief Funct Genomic Proteomic 3:142-56

Showing the most recent 10 out of 155 publications